Weighing risks and benefits of liraglutide--the FDA's review of a new antidiabetic therapy.
作者信息
Parks Mary, Rosebraugh Curtis
机构信息
Division of Metabolism and Endocrinology Products, Office of New Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.
出版信息
N Engl J Med. 2010 Mar 4;362(9):774-7. doi: 10.1056/NEJMp1001578. Epub 2010 Feb 17.
PMID:20164475
Abstract
摘要
Zotero 插件